Targeting shared molecular etiologies to accelerate drug development for rare diseases.
Zanello G, Garrido-Estepa M, Crespo A, O'Connor D, Nabbout R, Waters C, Hall A, Taglialatela M, Chan CH, Pearce DA, Dooms M, Brooks PJ.
Zanello G, et al.
EMBO Mol Med. 2023 Jul 10;15(7):e17159. doi: 10.15252/emmm.202217159. Epub 2023 Jun 27.
EMBO Mol Med. 2023.
PMID: 37366158
Free PMC article.
Review.